McCarthy, Helen S.Williams, John H. H.Davie, Michael W. J.Marshall, Michael J.2012-02-032012-02-032008-11-20Journal of Cellular Physiology, 218(2), 2009, pp. 350-3540021-95411097-465210.1002/jcp.21600http://hdl.handle.net/10034/208689This article is not available through ChesterRep.This article discusses how osteoprotegerin (OPG) production by osteoblastic cells was stimulated by platelet-derived growth factor (PDGF) in two human osteosarcoma cell lines (MG63, Saos-2), a mouse pre-osteoblastic cell line (MC3T3-E1) and human bone marrow stromal cells (hMSC) by 152%, 197%, 113% and 45% respectively over 24 h. OPG was measured in the cell culture medium by immunoassay. PDGF isoforms AA, BB and AB show similar stimulation of OPG production. Message for OPG was also increased similarly to the increased secretion into the culture medium. Using specific inhibitors of cell signalling the authors demonstrate that PDGF acts through the PDGF receptor, PKC, PI3K, ERK and P38 and not via NF-kB or JNK. The importance of PDGF in fracture healing suggests a role for OPG production in countering bone resorption during the early phase of this process.enosteoprotegerin (OPG)platelet-derived growth factor (PDGF)ArticleJournal of Cellular Physiology